Risperdal Claims
If you or any of his men ones presented growth of male breasts, a condition known as gynecomastia, after taking the anti-psychotic drug Risperdal, you may be eligible to file for Risperdal seeking compensation for pain, suffering and regret that the situation has caused. A growing number of lawsuits have been filed on behalf of men and boys who allegedly developed gynecomastia, which could have resulted in nursing procedures, liposuction and mastectomy to remove breast tissue allegedly caused by the use of Risperdal. The court records indicate that the releases of Risperdal were granted in some cases.
In addition to his active research on potential demands of Risperdal, lawyers are also offering free and confidential assessments for the demands of Invega individuals who allegedly developed the same condition to be taking another antipsychotic manufactured by a subsidiary of Johnson & Johnson, Janssen Pharmaceuticals Inc. Risperdal lawyers of our firm are there to answer any legal questions you may have in relation to cases involving either drug.
Who Can File an Application for Risperdal?
Men or children who developed gynecomastia after taking Risperdal, a drug marketed by Jenssen, may be eligible to file lawsuits against the manufacturer. Approved to treat irritability in children aged 5-16 years old with autism as well as schizophrenia and bipolar disorder in adolescents and adults, Risperdal is an atypical antipsychotic medication. Another use of the drug, without indication for this is the treatment of ADHD. However, since its adoption in 1993, Risperdal has been linked to movement disorders and diabetes, along with gynecomastia. A wave of research linking drug use to the development of breasts is published in the Journal of Clinical Psychopharmacology US, for example, a report that was published in 2006 and in which high levels of a hormone associated encountered the development of female breasts in some children taking Risperdal. In 2009, the Journal of Child and Adolescent Psychopharmacology published research suggesting that high levels of the hormone prolactin could last up to two years in individuals who take Risperdal, which focuses on the serotonin and dopamine in the brain. In coordination with these data, there have been many claims of Risperdal in US courts against Johnson & Johnson and Janssen unit. The plaintiffs involved in these cases allege that the companies were aware of the risks associated with Risperdal, but hid this information from the public. So far, there have been no collective demands of Risperdal, but a report published in October 2012 by Bloomberg.com revealed that companies had begun to settle Risperdal some individual claims that had been filed in state process of the State Court Pennsylvania.
Allegations Demand gynecomastia Risperdal
The following symptoms have been associated with gynecomastia of Risperdal, and have been alleged in a growing number of claims about the drug:
As the plaintiffs allegedly experienced these side effects, the marketing of Risperdal and other drugs popping Johnson & Johnson has recently been under fire. In 2012, an article in the Wall Street Journal said that the manufacturer charges allegedly settlement with the federal government regarding the marketing of the drug, but threatened to end a $ 212 million to US Justice Department in the summer of 2013. The organization wanted Johnson & Johnson recognized the fact that they had minimized the side effects of Risperdal, which include its relationship with increased prolactin levels in children. The Wall Street Journal report states that Johnson & Johnson doubts about the settlement agreement resulted from concerns about the effect this would have on the demands of Risperdal.
How filed for gynecomastia Risperdal?
If you or any of his men ones presented growth of male breasts, a condition known as gynecomastia, after taking the anti-psychotic drug Risperdal, you may be eligible to file for Risperdal seeking compensation for pain, suffering and regret that the situation has caused. A growing number of lawsuits have been filed on behalf of men and boys who allegedly developed gynecomastia, which could have resulted in nursing procedures, liposuction and mastectomy to remove breast tissue allegedly caused by the use of Risperdal. The court records indicate that the releases of Risperdal were granted in some cases.
In addition to his active research on potential demands of Risperdal, lawyers are also offering free and confidential assessments for the demands of Invega individuals who allegedly developed the same condition to be taking another antipsychotic manufactured by a subsidiary of Johnson & Johnson, Janssen Pharmaceuticals Inc. Risperdal lawyers of our firm are there to answer any legal questions you may have in relation to cases involving either drug.
Who Can File an Application for Risperdal?
Men or children who developed gynecomastia after taking Risperdal, a drug marketed by Jenssen, may be eligible to file lawsuits against the manufacturer. Approved to treat irritability in children aged 5-16 years old with autism as well as schizophrenia and bipolar disorder in adolescents and adults, Risperdal is an atypical antipsychotic medication. Another use of the drug, without indication for this is the treatment of ADHD. However, since its adoption in 1993, Risperdal has been linked to movement disorders and diabetes, along with gynecomastia. A wave of research linking drug use to the development of breasts is published in the Journal of Clinical Psychopharmacology US, for example, a report that was published in 2006 and in which high levels of a hormone associated encountered the development of female breasts in some children taking Risperdal. In 2009, the Journal of Child and Adolescent Psychopharmacology published research suggesting that high levels of the hormone prolactin could last up to two years in individuals who take Risperdal, which focuses on the serotonin and dopamine in the brain. In coordination with these data, there have been many claims of Risperdal in US courts against Johnson & Johnson and Janssen unit. The plaintiffs involved in these cases allege that the companies were aware of the risks associated with Risperdal, but hid this information from the public. So far, there have been no collective demands of Risperdal, but a report published in October 2012 by Bloomberg.com revealed that companies had begun to settle Risperdal some individual claims that had been filed in state process of the State Court Pennsylvania.
Allegations Demand gynecomastia Risperdal
The following symptoms have been associated with gynecomastia of Risperdal, and have been alleged in a growing number of claims about the drug:
- Inflammation of breast tissue
- Breast tenderness
- Breast pain
- Nipple discharge from one or both breasts
As the plaintiffs allegedly experienced these side effects, the marketing of Risperdal and other drugs popping Johnson & Johnson has recently been under fire. In 2012, an article in the Wall Street Journal said that the manufacturer charges allegedly settlement with the federal government regarding the marketing of the drug, but threatened to end a $ 212 million to US Justice Department in the summer of 2013. The organization wanted Johnson & Johnson recognized the fact that they had minimized the side effects of Risperdal, which include its relationship with increased prolactin levels in children. The Wall Street Journal report states that Johnson & Johnson doubts about the settlement agreement resulted from concerns about the effect this would have on the demands of Risperdal.
How filed for gynecomastia Risperdal?